Pharmacokinetics and safety of cefamandole in infants and children

C. T. Chang, A. J. Khan, M. M. Agbayani, R. Jhaveri, I. Amin, H. E. Evans

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Cefamandole, a new cephalosporin antibiotic, has greater activity against common pathogens, including Escherichia coli, Haemophilus influenzae, and Proteus (including indole-positive strains), than available cephalosporin drugs. The authors have evaluated the safety and pharmacokinetics of this drug in 30 infants and children. Blood levels and urinary excretion of the drug were similar to those previously found in adults. The only side effects were mild and transient elevation of serum glutamic oxalacetic transaminase in 12 patients and of blood urea nitrogen in 1 patient in whom serum creatinine remained normal and unchanged.

Original languageEnglish (US)
Pages (from-to)838-841
Number of pages4
JournalUnknown Journal
Volume14
Issue number6
DOIs
StatePublished - 1978
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Pharmacokinetics and safety of cefamandole in infants and children'. Together they form a unique fingerprint.

Cite this